中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [28]
昆明动物研究所 [11]
武汉病毒研究所 [8]
上海生物化学与细胞生... [8]
中国科学院大学 [5]
昆明植物研究所 [4]
更多
采集方式
OAI收割 [80]
iSwitch采集 [14]
内容类型
期刊论文 [90]
学位论文 [4]
发表日期
2023 [4]
2022 [2]
2021 [4]
2020 [3]
2019 [4]
2018 [6]
更多
学科主题
Pharmacolo... [5]
Infectious... [4]
Virology [4]
Biochemist... [3]
Gastroente... [2]
Pharmacolo... [2]
更多
筛选
浏览/检索结果:
共94条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
发表日期升序
发表日期降序
Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 卷号: 9, 期号: 1, 页码: 14
作者:
Xie, Xiong
;
Lan, Qiaoshuai
;
Zhao, Jinyi
;
Zhang, Sulin
;
Liu, Lu
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/05/07
A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir
期刊论文
OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 10
作者:
Zhang, Yumin
;
Sun, Yuan
;
Xie, Yuanchao
;
Shang, Weijuan
;
Wang, Zhen
  |  
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2023/12/08
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
期刊论文
OAI收割
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 卷号: 120, 期号: 18, 页码: 11
作者:
Xu, Haiyu
;
Li, Shufen
;
Liu, Jiayuan
;
Cheng, Jinlong
;
Kang, Liping
  |  
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2023/10/17
COVID-19
traditional Chinese medicine
TCMT-NDRD
antivirus
anti-inflammation
Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2
期刊论文
OAI收割
Signal Transduction and Targeted Therapy, 2023, 卷号: 8, 期号: 5, 页码: 2384-2391
作者:
Xu, Zhijian
;
Shi, Danrong
;
Han, Jianbao
;
Ling, Yun
;
Jiang, Xiangrui
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2024/03/27
Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
期刊论文
OAI收割
CELL DISCOVERY, 2023, 卷号: 9, 期号: 1, 页码: 15
作者:
Xia, Bingqing
;
Pan, Xiaoyan
;
Luo, Rong-Hua
;
Shen, Xurui
;
Li, Shuangqu
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2023/04/10
Abnormal global alternative RNA splicing in COVID-19 patients
期刊论文
OAI收割
PLOS GENETICS, 2022, 卷号: 18, 期号: 4, 页码: 22
作者:
Wang, Changli
;
Chen, Lijun
;
Chen, Yaobin
;
Jia, Wenwen
;
Cai, Xunhui
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/06/15
Bioactive Effects of Curcumin in Human Immunodeficiency Virus Infection Along with the Most Effective Isolation Techniques and Type of Nanoformulations
期刊论文
OAI收割
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2022, 卷号: 17, 期号: 0, 页码: 3619-3632
作者:
Butnariu, Monica
;
Quispe, Cristina
;
Koirala, Niranjan
;
Khadka, Sujan
;
Salgado-Castillo, Carla Marina
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2022/11/09
MICROWAVE-ASSISTED EXTRACTION
ANTIRETROVIRAL THERAPY
BIOLOGICAL-ACTIVITIES
HIV-1 INTEGRASE
BREAST-CANCER
UP-REGULATION
NANOPARTICLES
DERIVATIVES
MECHANISMS
INHIBITION
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 7
作者:
Wang, Yi
;
Fang, Sui
;
Wu, Yan
;
Cheng, Xi
;
Zhang, Lei-ke
  |  
收藏
  |  
浏览/下载:67/0
  |  
提交时间:2021/08/17
SARS-CoV-2
envelope protein (2-E)
cation channel
high-throughput screening (HTS)
anti-virus
Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective
期刊论文
OAI收割
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 卷号: 90, 页码: 19
作者:
Bolarin, Joshua Adedeji
;
Oluwatoyosi, Mercy Adaramodu
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2021/03/29
COVID-19
Therapeutics
Drug interaction
Antiviral drugs
Health and safety
Therapeutic drugs for SARS-CoV-2 treatment: Current state and perspective
期刊论文
OAI收割
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 卷号: 90, 页码: 19
作者:
Bolarin, Joshua Adedeji
;
Oluwatoyosi, Mercy Adaramodu
;
Orege, Joshua Iseoluwa
;
Ayeni, Emmanuel Ayodeji
;
Ibrahim, Yusuf Ajibola
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2021/05/25
COVID-19
Therapeutics
Drug interaction
Antiviral drugs
Health and safety